UBS Group’s Cingulate CING Stock Holding History
Bought
Maintained
Sold
Other funds holding CING
VCM
KAS
XT
BAM
VFT
QC
HF
UBS Group's CING Position: Q1 2026 in Review
UBS Group reduced its Cingulate (CING) stake by 60% in Q1 2026, selling an estimated $106K and leaving 11,033 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7198.
UBS Group first reported a position in CING in Q4 2021 and has held it in 12 quarters since. The position peaked at $120K in Q4 2025. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.
- UBS Group held 11,033 shares of Cingulate worth $68.5K as of Q1 2026.
- UBS Group sold 16,651 Cingulate shares in Q1 2026, an estimated $106K.
- Cingulate made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7198 holding.
- UBS Group first reported a position in Cingulate in Q4 2021 and has held it in 12 quarters since.
- UBS Group's Cingulate position peaked at $120K in Q4 2025.
- 27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.